Knickerbocker Aron Marc 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Feb 7, 2019
Insider Transaction Report
Form 4
Knickerbocker Aron Marc
SVP & Chief Business Officer
Transactions
- Tax Payment
Common Stock
2019-02-05$11.43/sh−2,996$34,244→ 195,063 total
Holdings
- 14,238(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Includes 641 shares acquired on May 15, 2018 and 452 shares acquired on November 15, 2018 pursuant to Five Prime Therapeutics, Inc.'s 2013 Employee Stock Purchase Plan.